G1 Therapeutics, Inc.

Home » G1 Therapeutics, Inc.

Secondary

G1 Therapeutics, Inc.

We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for the treatment of patients with cancer.

Symbol

GTHX

Last Closing Price
$25.10

Shares
3,000,000

Anticipated Date
TBD

Underwriters
J.P. Morgan, Cowen

To view the prospectus for G1 Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253